Response to US review rules on patent subject matter of traditional Chinese medicine compositions / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 627-630, 2018.
Article
Dans Chinois
| WPRIM
| ID: wpr-771691
ABSTRACT
The United States Patent and Trademark Office(USPTO) issued Interim Guidance on Patent Subject Matter Eligibility on December 16, 2014, bringing certain effects to the review rules on patent application of Chinese medicine compositions. Based on the Interim Guidance, cases analysis was used in this paper to analyze the patent subject matter issues of traditional Chinese medicine compositions in the United States. The researches have shown that the application documents should be properly written in the United States when the patent for Chinese medicine compositions is applied, which can improve the probability of authorization.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Brevets comme sujet
/
Normes de référence
/
Recherche
/
États-Unis
/
Médicaments issus de plantes chinoises
/
Chimie
/
Médecine traditionnelle chinoise
Type d'étude:
Etude diagnostique
Pays comme sujet:
Amérique du Nord
langue:
Chinois
Texte intégral:
China Journal of Chinese Materia Medica
Année:
2018
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS